Table 2.
Binding and functional assay results of monomers and dendrimers at four subtypes of hARs.a
cmpd | bindingb at ARs | activationc at ARs | |||||||
---|---|---|---|---|---|---|---|---|---|
hA1 | hA2A | hA3 | hA2A | hA2B | |||||
Ki [nM] | % inhibition | Ki [nM] | % inhibition | Ki [nM] | % inhibition | EC50 [nM] | % activation | % activation | |
1 | 5780 ± 590 | 24.9 ± 4.6 | 67 ± 19 | 84.7 ± 0.9 | 247 ± 79 | 59.8 ± 4.4 | 53.0 ± 16.0 | 100 ± 10 | 3.6 ± 6.3 |
2 | 168 ± 36 | 56.9 ± 9.1 | 12 ± 6 | 101 ± 1 | 38 ± 11 | 85.3 ± 3.2 | 8.2 ± 1.7 | 96.0 ± 6.0 | 5.5 ± 4.7 |
3 | 984 ± 223 | 36.9 ± 7.5 | 210 ± 19 | 82.1 ± 0.3 | 58 ± 24 | 85.2 ± 11.4 | 51.0 ± 8.0 | 103 ± 5 | -1.7 ± 5.0 |
7a | n.d.d | 5.5 ± 8.8 | n.d.d | 1.6 ± 7.4 | n.d.d | -13.4 ± 2.7 | n.d.d | 2.4 ± 1.7 | 5.3 ± 8.9 |
7b | n.d.d | 13.8 ± 4.5 | n.d.d | -11.6 ± 2.5 | n.d.d | -17.2 ± 5.2 | n.d.d | n.a.d | 1.6 ± 7.3 |
7d | n.d.d | 7.1 ± 4.5 | n.d.d | 3.2 ± 4.9 | n.d.d | -7.5 ± 2.2 | n.d.d | n.a.d | -4.4 ± 3.8 |
9a | n.d.d | 12.2 ± 1.6 | 488 ± 59 | 61.4 ± 2.0 | n.d.d | 24.4 ± 6.5 | n.d.d | 92.6 ± 5.4 | 1.4 ± 5.5 |
9b | n.d.d | 19.3 ± 3.6 | 496 ± 18 | 62.7 ± 1.2 | n.d.d | 27.6 ± 3.2 | n.d.d | 101 ± 5 | 16.6 ± 3.7 |
9d | n.d.d | 13.3 ± 3.1 | 752 ± 34 | 55.8 ± 1.8 | n.d.d | 25.4 ± 4.0 | n.d.d | 91.0 ± 8.3 | 9.4 ± 5.4 |
10c | 4870 ± 1360 | 19.9 ± 4.8 | 151 ± 36 | 81.2 ± 1.5 | 1130 ± 310 | 29.0 ± 12.0 | 11.2 ± 4.9 | 90.0 ± 6.7 | 2.8 ± 1.4 |
10d | 4230 ± 1310 | 19.8 ± 2.6 | 215 ± 12 | 75.5 ± 3.1 | 1320e | 24.4 ± 8.0 | 60.6 ± 12.8 | 97.0 ± 7.1 | 3.3 ± 3.0 |
Values are presented as the mean ± standard error of three or more independent experiments. The hA1, hA2B, and hA3 ARs were expressed in CHO cells and the hA2A AR in HEK-293 cells for binding and in CHO cells for the functional assay.
Ki values were determined through the radioligand binding, and the percent inhibition refers to the inhibition of binding at 1 μM.
EC50 values were determined by measuring the degree of stimulation of adenylate cyclase in cells stably expressing hA2A or hA2B AR. Percent activation refers to the activation of adenylate cyclase in comparison to the effects exerted by the full agonist NECA (100%) at 10 μM.
n.d. = not determined, i.e., binding/functional experiment was not conducted, or n.a. = no binding/activation was detected under the given assay conditions.
Performed only once.